Biocept (BIOC) Reports Q3 Loss of $2.42/Share

Biocept (NASDAQ: BIOC) reported Q3 EPS of ($2.42), versus ($5.90) reported last year. Revenue for the quarter came in at $762 thousand, versus $1.1 million reported last year.

For earnings history and earnings-related data on Biocept (BIOC) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BitFuFu Inc. (FUFU) Misses Q2 EPS by 13c
• RBC Capital Downgrades Hermes International (RMS:FP) (HESAY) to Sector Perform